Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ALNYLAM PHARMACEUTICALS, INC. : BMO RAISES TARGET PRICE TO $292 FROM $290

ALNYLAM PHARMACEUTICALS, INC. : BMO RAISES TARGET PRICE TO $292 FROM $290

ReutersReuters2026/11/05 12:08
By:Reuters
ALNYLAM PHARMACEUTICALS, INC.
: BMO RAISES TARGET PRICE TO $292 FROM $290
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like